Valuation (93%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.93 | N/A |
| PEG Ratio (TTM) | 0.30 | N/A |
| P/S Ratio (TTM) | 1.82 | N/A |
| P/B Ratio (TTM) | 0.89 | N/A |
| P/FCF Ratio (TTM) | 7.99 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.15 | N/A |
| Price to 5YR AVG FCF Ratio | 7.13 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.07% | N/A |
| ROE (TTM) | 10.37% | N/A |
| Net Profit Margin (TTM) | 20.66% | N/A |
| ROIC 5YR AVG | 12.29% | N/A |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 186.72% | 32.29% | 10.14% |
| Revenue | 11.00% | 15.54% | 10.74% |
| Net Income | 192.71% | 34.42% | 12.65% |
| Cash Flow | 10.02% | -3.81% | 62.02% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.29 | N/A |
| Quick Ratio (TTM) | 0.29 | N/A |
| D/E Ratio (TTM) | 0.66 | N/A |
| Interest Coverage (TTM) | 1.13 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.04 | N/A |
| LTL to 5YR AVG FCF | 4.74 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.91% | N/A |